Showing results (281-290 of 333) with videos related to

Sort By:
Pageof 34
Future Medicinal Chemistry|April 2, 2011
Reaction-driven de novo design, synthesis and testing of potential type II kinase inhibitorsGisbert Schneider, Tim Geppert, Markus Hartenfeller, et al.
RSC Medicinal Chemistry|July 19, 2024
Geometric deep learning-guided Suzuki reaction conditions assessment for applications in medicinal chemistryKenneth Atz, David F Nippa, Alex T Müller, et al.
Bioorganic & Medicinal Chemistry Letters|March 30, 2010
Truxillic acid derivatives act as peroxisome proliferator-activated receptor gamma activatorsRamona Steri, Matthias Rupp, Ewgenij Proschak, et al.
Angewandte Chemie (International Ed. in English)|June 13, 2015
Fragment-Based De Novo Design Reveals a Small-Molecule Inhibitor of Helicobacter Pylori HtrAAnna M Perna, Tiago Rodrigues, Thomas P Schmidt, et al.
Communications Chemistry|November 21, 2023
Identifying opportunities for late-stage C-H alkylation with high-throughput experimentation and in silico reaction screeningDavid F Nippa, Kenneth Atz, Alex T Müller, et al.
Angewandte Chemie (International Ed. in English)|August 24, 2017
Discovery of a Novel Inhibitor of the Hedgehog Signaling Pathway through Cell-based Compound Discovery and Target PredictionLea Kremer, Carsten Schultz-Fademrecht, Matthias Baumann, et al.
The Journal of Organic Chemistry|March 16, 2018
Total Synthesis of Ripostatin B and Structure-Activity Relationship Studies on Ripostatin AnalogsFlorian Glaus, Darija Dedić, Priyanka Tare, et al.
Chemmedchem|April 4, 2009
Homology model adjustment and ligand screening with a pseudoreceptor of the human histamine H4 receptorYusuf Tanrikulu, Ewgenij Proschak, Tim Werner, et al.
Chemical Science|January 29, 2016
Inhibiting Helicobacter pylori HtrA protease by addressing a computationally predicted allosteric ligand binding siteAnna Maria Perna, Felix Reisen, Thomas P Schmidt, et al.
Pageof 34